The immunotherapy used in the trial was nivolumab ( Opdivo ), a drug delivered intravenously that works by disabling a ...

The BC Cancer Foundation is launching a fundraising campaign to support the next three years of immunotherapy research at BC ...

This approach aims to improve treatment for patients with this highly aggressive and treatment-resistant type of breast ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research.

Patients may require life-long monitoring and a collaborative engagement with subspecialists to keep well in the long -term,” ...

Results of CHANCE 2005/CARES-005 study were unveiled by Dr Gao-Jun Teng from Zhongda Hospital, Southeast University, China, ...

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, ...

Tevogen Bio is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and ...

Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially ...

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...

Epitopea, a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA-based immunotherapies, ...